跳至主要内容
临床试验/NL-OMON56549
NL-OMON56549尚未招募不适用

The influence of cognitive behavioural therapy for insomnia (CBT-I) on the pathophysiology of major depressive disorder: A pilot study - The influence of CBT-I on MDD pathophysiology

niversitair Medisch Centrum Groningen0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age 18 years or older.
  • - Primary diagnosis for MDD (without psychotic features) based on Diagnostic
  • and Statistical Manual 5th edition (DSM-5) criteria ascertained by the Mini
  • International Neuropsychiatric Interview (MINI).
  • - Co-morbid clinical insomnia (ISI >= 15)
  • - Stable pharmacological treatment for MDD. This pertains to all medication
  • described in the clinical guideline for the treatment of MDD including
  • antidepressant monotherapy, combination therapy (i.e., multiple antidepressants
  • provided simultaneously), and augmentation therapy (i.e., antidepressants
  • combined with lithium or atypical antipsychotics). No changes in
  • pharmacological MDD treatment (type and dosage) should be anticipated during
  • the study period or present within the four weeks prior to participation.

排除标准

  • - Comorbid diagnoses for a psychiatric disorder within one of the following
  • diagnostic groups:
  • o Bipolar disorders
  • o Schizophrenia or other psychotic disorders
  • o Delirium, dementia, and amnestic and other cognitive disorders
  • o Substance use disorder
  • - Current or recent (four weeks prior to inclusion) use of non-prescribed
  • psychoactive compounds (i.e., recreational drugs, herbal medicine etc.) not
  • including caffeine and alcohol.
  • - Pregnancy or breastfeeding.

研究者

相似试验